Not Signed In - Arena Pharmaceuticals Presents Favorable Results From Phase 1 Studies Of APD125, A Novel Insomnia Compound
Thu, 22 Jun 2006 06:00 AM EST
... ArenaPharmaceuticals, Inc. (Nasdaq: ARNA) announced that it is presentingfavorable results from Phase 1 clinical studies of APD125, a novel insomniacompound, today at the 20th Anniversary Meeting of the AssociatedProfessional Sleep Societies (APSS) in Salt Lake City, UT. [click link for full article] ...
Related Topics
- Insomnia
- Aspirin and Carisoprodol
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Aspirin, Butalbital, Caffeine and Codeine
- Propoxyphene
- Asian American
- Perimenopause
- Radiation Studies
- Zidovudine Capsule
- Hypersomnia
- Fractures
- Zidovudine Injection
- Clinical Trials
- Codeine Tablets
- Tiagabine
- Veterans
- Zidovudine Oral Syrup
- CK
- Veteran's Health
email this page
print this page
bookmark this page
feedback on this page
